SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells

Hua Geng, Saravanan Subramanian, Longtao Wu, Heng-Fu Bu, Xiao Wang, Chao Du, Isabelle G. De Plaen, Xiao-Di TanFrontiers in Immunology 2021 · DOI

Abstract

Infection with SARS-CoV-2 causes COVID-19, leading to significant lung tissue damage. The open reading frame 8 (ORF8) protein is a unique accessory protein with poorly understood cellular functions. This study examined the cellular distribution of ORF8 and its role in lung epithelial cell proliferation and antiviral immunity. Ectopically expressed ORF8 was found to form aggregates in the cytosol and nucleus, driven by an intrinsic aggregation characteristic in its N-terminal residues 1-18. While ORF8 expression did not affect cell proliferation or cycle progression, it significantly suppressed the basal expression of antiviral molecules (DHX58, ZBP1, MX1, MX2) and attenuated the induction of these molecules by IFNγ. These findings suggest ORF8 facilitates viral escape from the host innate immune response.

Introduction

SARS-CoV-2 infection is characterized by severe lung injury, yet the specific mechanisms by which viral proteins manipulate host cell biology remain a subject of intense study. While structural proteins like Spike (S) and Nucleocapsid (N) are well-characterized, "accessory proteins"—which are not strictly required for viral replication but often modulate host immunity—are less understood. ORF8 is one such protein, notable for its high rate of evolution and unique sequence. This research investigates where ORF8 localizes within human lung cells and how it might interfere with the interferon (IFN) response, the body's primary defense against viral infection.

Methods

The study utilized human lung epithelial cells (A549) and HEK293 cells as models. To track the protein, researchers engineered expression plasmids containing the ORF8 sequence (derived from RefSeq MN908947) fused to Enhanced Green Fluorescent Protein (eGFP).

Schematic representation of the SARS-CoV-2 genome and the ORF8-EGFP expression construct used in the study.

Protein localization was visualized using high-resolution "Thunder" microscopy and immunofluorescent staining. The aggregation potential of ORF8 was predicted in silico using the PASTA 2.0 algorithm. Functional impacts on the cell cycle were assessed via flow cytometry, and the expression of Interferon-Stimulated Genes (ISGs) was quantified using RT-qPCR following treatment with IFNβ or IFNγ.

Results

ORF8 Forms Intracellular Aggregates

Bioinformatic analysis identified a highly "sticky" region at the N-terminus (residues 1-18) of ORF8, suggesting a natural propensity to clump. Experimental results confirmed this: while control eGFP was distributed evenly throughout the cell, ORF8-eGFP formed distinct, dense aggregates in both the cytoplasm and the nucleus.

Selective Suppression of Antiviral Immunity

Interestingly, the presence of these ORF8 aggregates did not impair basic cellular functions like growth or division. Instead, ORF8 acted as a selective immune suppressor. It lowered the baseline levels of several key antiviral sensors, including DHX58 and ZBP1, and effectors like MX1 and MX2.

Validation of ORF8-GFP expression. (A) Construct schematic. (B) Western blot showing the expected molecular weight of the ORF8-GFP fusion protein (~37 kDa). (C) Flow cytometry data indicating transfection efficiency.

Crucially, ORF8 specifically hindered the cell's ability to respond to Type II interferon (IFNγ). While the response to Type I interferon (IFNβ) remained largely intact, the "boost" in antiviral gene expression normally triggered by IFNγ was significantly blunted in cells expressing ORF8.

Discussion

The ability of ORF8 to form stable aggregates without killing the host cell suggests a sophisticated strategy for long-term immune evasion. By selectively blocking the IFNγ pathway, SARS-CoV-2 can bypass a critical arm of the innate immune system.

The stability of these aggregates raises questions about their persistence. The authors hypothesize that if ORF8 aggregates remain in lung cells after the virus has been cleared, they might contribute to the prolonged inflammatory or respiratory issues seen in "Long-COVID" patients. Future research is needed to identify the specific host proteins that ORF8 interacts with to achieve this targeted suppression.

Summary updated

Abstract

Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a disease that involves significant lung tissue damage. How SARS-CoV-2 infection leads to lung injury remains elusive. The open reading frame 8 (ORF8) protein of SARS-CoV-2 (ORF8<sup>SARS-CoV-2</sup>) is a unique accessory protein, yet little is known about its cellular function. We examined the cellular distribution of ORF8<sup>SARS-CoV-2</sup> and its role in the regulation of human lung epithelial cell proliferation and antiviral immunity. Using live imaging and immunofluorescent staining analyses, we found that ectopically expressed ORF8<sup>SARS-CoV-2</sup> forms aggregates in the cytosol and nuclear compartments of lung epithelial cells. Using <i>in silico</i> bioinformatic analysis, we found that ORF8<sup>SARS-CoV-2</sup> possesses an intrinsic aggregation characteristic at its N-terminal residues 1-18. Cell culture did not reveal any effects of ORF8<sup>SARS-CoV-2</sup> expression on lung epithelial cell proliferation and cell cycle progression, suggesting that ORF8<sup>SARS-CoV-2</sup> aggregates do not affect these cellular processes. Interestingly, ectopic expression of ORF8<sup>SARS-CoV-2</sup> in lung epithelial cells suppressed basal expression of several antiviral molecules, including DHX58, ZBP1, MX1, and MX2. In addition, expression of ORF8<sup>SARS-CoV-2</sup> attenuated the induction of antiviral molecules by IFNγ but not by IFNβ in lung epithelial cells. Taken together, ORF8<sup>SARS-CoV-2</sup> is a unique viral accessory protein that forms aggregates when expressing in lung epithelial cells. It potently inhibits the expression of lung cellular anti-viral proteins at baseline and in response to IFNγ in lung epithelial cells, which may facilitate SARS-CoV-2 escape from the host antiviral innate immune response during early viral infection. In addition, it seems that formation of ORF8<sup>SARS-CoV-2</sup> aggregate is independent from the viral infection. Thus, it would be interesting to examine whether any COVID-19 patients exhibit persistent <i>ORF8 SARS-CoV-2</i> expression after recovering from SARS-CoV-2 infection. If so, the pathogenic effect of prolonged ORF8<sup>SARS-CoV-2</sup> expression and its association with post-COVID symptoms warrant investigation in the future.
BibTeX
@inproceedings{geng2021sars,
  author = {Hua Geng and Saravanan Subramanian and Longtao Wu and Heng-Fu Bu and Xiao Wang and Chao Du and Isabelle G. De Plaen and Xiao-Di Tan},
  title = {{SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells}},
  booktitle = {Frontiers in Immunology},
  year = {2021},
  doi = {10.3389/fimmu.2021.679482},
}
Figure